Oric Pharmaceuticals, Inc. ORIC

13.16 (0.02) (0.15%) as of 25 Sep

Market cap: $1.4B
P/E: 0.0×

Follow ORIC

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17
Cash and Short Term Investments	281.49	255.96	208.19	206.27	236.98	293.60	89.16	42.64	25.82
Other current assets	—	—	—	—	—	—	—	—	0.79
Total current assets	288.47	262.25	212.60	210.46	240.52	296.70	90.00	43.72	26.61
Property, Plant, Equpment (Net)	2.42	2.92	2.86	3.25	2.41	1.98	2.24	2.51	2.90
Long-Term Investments	110.76	—	26.85	21.95	43.39	—	—	—	—
Goodwill and Intangible Assets (Total)	—	—	—	—	—	—	—	0.00	—
Long-term assets (Other)	7.25	8.97	9.70	11.52	12.32	0.32	1.85	0.50	0.51
Total non-current assets	120.42	11.89	39.41	36.72	58.12	2.30	4.09	—	—
Total Assets	408.89	274.14	252.01	247.18	298.64	299.00	94.09	0.00	0.00
Accounts Payable	3.82	1.55	0.94	1.32	1.89	0.76	0.15	0.45	0.94
Current Part of Capital Lease	—	—	—	—	—	—	—	0.00	—
Current Part of Taxes to Pay	—	—	—	—	—	—	—	0.00	—
Other current liabilities	—	—	—	—	—	—	—	—	1.67
Total current liabilities	20.42	24.85	20.46	15.39	15.15	9.00	5.35	2.60	2.61
Non-current Revenue (Deferred)	—	—	—	—	—	0.22	0.77	0.00	1.69
Liabilities (Preferred Stock)	—	—	—	—	—	—	178.06	—	—
Minority Interests	—	—	—	—	—	—	—	0.00	—
Non-current Liabilities (Other)	4.11	6.17	7.46	9.44	10.52	0.22	—	0.05	0.00
Total non-current liabilities	4.11	6.17	7.46	9.44	10.52	0.22	178.82	—	—
Total liabilities	24.53	31.02	27.92	24.83	25.67	9.22	184.18	0.00	4.30
Additional Paid In Capital	1,075.81	805.51	658.75	557.87	518.18	456.20	2.61	0.00	—
Preferred Stock (Total)	—	—	—	—	—	—	—	0.00	—
Common Stock (Net)	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Retained Earnings	(692.24)	(562.77)	(434.93)	(334.23)	(245.11)	(166.39)	(92.69)	(65.81)	(44.44)
Treasury Stock	—	—	—	—	—	—	—	0.00	—
Shareholders Equity (Other)	—	—	—	—	—	—	—	0.00	—
Common Equity (Total)	384.36	243.12	224.09	222.35	272.98	289.78	(90.08)	(64.43)	(43.61)
Shareholders Equity (Total)	384.36	243.12	224.09	222.35	272.98	289.78	(90.08)	0.00	25.73
Shareholders Equity and Liabilities (Total)	408.89	274.14	252.01	247.18	298.64	299.00	94.09	0.00	—
Shares (Common)	98.53	71.02	54.87	45.09	39.43	36.67	1.98	—	—
Shareholders Equity (Tangible)	384.36	243.12	224.09	222.35	272.98	289.78	(90.08)	—	—
Net Debt	(281.49)	(255.96)	(208.19)	(206.27)	(236.98)	(293.60)	(89.16)	(42.64)	(25.82)
Total Debt	—	—	—	12.10	12.44	—	—	—	—

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Oric Pharmaceuticals, Inc. ORIC